SAN DIEGO, March 15 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that Neurocrine Biosciences will present at the Lehman Brothers Annual Global Healthcare Conference. The live presentation takes place Tuesday, March 20, 2007 at 8:30 a.m. Eastern Time (ET) /5:30 a.m. Pacific Time (PT). The presentation will be simultaneously webcast and may be accessed on the Company’s website at http://www.neurocrine.com
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be archived on the website for fourteen days.
About Neurocrine
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical Company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, endometriosis, pain, irritable bowel syndrome, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company’s website via the Internet at http://www.neurocrine.com.
Neurocrine Biosciences, Inc.
CONTACT: Elizabeth Foster of Neurocrine Biosciences, +1-858-617-7600
Web site: http://www.neurocrine.com/
